Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin in Post Stroke Upper Limb Spasticity
NCT03908580Phase 4Completed
- Sponsor
- Medytox Inc.
- Start
- Sep 2013
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label, single-arm trial of Meditoxin in Spasticity, sponsored by Medytox Inc. Primary endpoint: Modified Ashworth Scale at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
Meditoxin
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT03908580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908580.